Randox recalls coronavirus test kits after safety concerns
Up to 750,000 unused testing kits to be recalled
Read More
Author: Lucy Parsons
Destiny Pharma’s novel antibiotic asset clears safety review
Independent Data Monitoring Committee recommended continuing Phase IIb study
Read More
Eli Lilly, Pieris collaborate on HER2-positive cancer clinical programme
Companies will focus on HER2-positive gastric cancer
Read More
Roche’s SMA treatment Evrysdi bags US approval
Drug cleared for use in SMA patients aged two months or older
Read More
Pfizer inks manufacturing deal with Gilead for COVID-19 med remdesivir
Pfizer becomes one of multiple external manufacturing organisations supporting scale-up of treatment
Read More- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
